Global Overactive Bladder Treatment Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Overactive Bladder Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drugs
1.2.3 Device
1.3 Market by Application
1.3.1 Global Overactive Bladder Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Overactive Bladder Treatment Market Perspective (2017-2028)
2.2 Overactive Bladder Treatment Growth Trends by Region
2.2.1 Overactive Bladder Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Overactive Bladder Treatment Historic Market Size by Region (2017-2022)
2.2.3 Overactive Bladder Treatment Forecasted Market Size by Region (2023-2028)
2.3 Overactive Bladder Treatment Market Dynamics
2.3.1 Overactive Bladder Treatment Industry Trends
2.3.2 Overactive Bladder Treatment Market Drivers
2.3.3 Overactive Bladder Treatment Market Challenges
2.3.4 Overactive Bladder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Overactive Bladder Treatment Players by Revenue
3.1.1 Global Top Overactive Bladder Treatment Players by Revenue (2017-2022)
3.1.2 Global Overactive Bladder Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Overactive Bladder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Overactive Bladder Treatment Revenue
3.4 Global Overactive Bladder Treatment Market Concentration Ratio
3.4.1 Global Overactive Bladder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Overactive Bladder Treatment Revenue in 2021
3.5 Overactive Bladder Treatment Key Players Head office and Area Served
3.6 Key Players Overactive Bladder Treatment Product Solution and Service
3.7 Date of Enter into Overactive Bladder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Overactive Bladder Treatment Breakdown Data by Type
4.1 Global Overactive Bladder Treatment Historic Market Size by Type (2017-2022)
4.2 Global Overactive Bladder Treatment Forecasted Market Size by Type (2023-2028)
5 Overactive Bladder Treatment Breakdown Data by Application
5.1 Global Overactive Bladder Treatment Historic Market Size by Application (2017-2022)
5.2 Global Overactive Bladder Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Overactive Bladder Treatment Market Size (2017-2028)
6.2 North America Overactive Bladder Treatment Market Size by Country (2017-2022)
6.3 North America Overactive Bladder Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Overactive Bladder Treatment Market Size (2017-2028)
7.2 Europe Overactive Bladder Treatment Market Size by Country (2017-2022)
7.3 Europe Overactive Bladder Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Overactive Bladder Treatment Market Size (2017-2028)
8.2 Asia-Pacific Overactive Bladder Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Overactive Bladder Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Overactive Bladder Treatment Market Size (2017-2028)
9.2 Latin America Overactive Bladder Treatment Market Size by Country (2017-2022)
9.3 Latin America Overactive Bladder Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Overactive Bladder Treatment Market Size (2017-2028)
10.2 Middle East & Africa Overactive Bladder Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Overactive Bladder Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Overactive Bladder Treatment Introduction
11.1.4 Allergan Revenue in Overactive Bladder Treatment Business (2017-2022)
11.1.5 Allergan Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Overactive Bladder Treatment Introduction
11.2.4 Astellas Pharma Revenue in Overactive Bladder Treatment Business (2017-2022)
11.2.5 Astellas Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Overactive Bladder Treatment Introduction
11.3.4 Pfizer Revenue in Overactive Bladder Treatment Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Overactive Bladder Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Overactive Bladder Treatment Business (2017-2022)
11.4.5 Johnson & Johnson Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Overactive Bladder Treatment Introduction
11.5.4 Medtronic Revenue in Overactive Bladder Treatment Business (2017-2022)
11.5.5 Medtronic Recent Development
11.6 KYORIN Pharmaceutical
11.6.1 KYORIN Pharmaceutical Company Detail
11.6.2 KYORIN Pharmaceutical Business Overview
11.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Introduction
11.6.4 KYORIN Pharmaceutical Revenue in Overactive Bladder Treatment Business (2017-2022)
11.6.5 KYORIN Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Overactive Bladder Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Drugs
Table 3. Key Players of Device
Table 4. Global Overactive Bladder Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Overactive Bladder Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Overactive Bladder Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Overactive Bladder Treatment Market Share by Region (2017-2022)
Table 8. Global Overactive Bladder Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Overactive Bladder Treatment Market Share by Region (2023-2028)
Table 10. Overactive Bladder Treatment Market Trends
Table 11. Overactive Bladder Treatment Market Drivers
Table 12. Overactive Bladder Treatment Market Challenges
Table 13. Overactive Bladder Treatment Market Restraints
Table 14. Global Overactive Bladder Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Overactive Bladder Treatment Market Share by Players (2017-2022)
Table 16. Global Top Overactive Bladder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Treatment as of 2021)
Table 17. Ranking of Global Top Overactive Bladder Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Overactive Bladder Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Overactive Bladder Treatment Product Solution and Service
Table 21. Date of Enter into Overactive Bladder Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Overactive Bladder Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Overactive Bladder Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Overactive Bladder Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Overactive Bladder Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Overactive Bladder Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Overactive Bladder Treatment Revenue Market Share by Application (2017-2022)
Table 29. Global Overactive Bladder Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Overactive Bladder Treatment Revenue Market Share by Application (2023-2028)
Table 31. North America Overactive Bladder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Overactive Bladder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Overactive Bladder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Overactive Bladder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Overactive Bladder Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Overactive Bladder Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Overactive Bladder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Overactive Bladder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Overactive Bladder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Overactive Bladder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Allergan Company Detail
Table 42. Allergan Business Overview
Table 43. Allergan Overactive Bladder Treatment Product
Table 44. Allergan Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 45. Allergan Recent Development
Table 46. Astellas Pharma Company Detail
Table 47. Astellas Pharma Business Overview
Table 48. Astellas Pharma Overactive Bladder Treatment Product
Table 49. Astellas Pharma Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 50. Astellas Pharma Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Overactive Bladder Treatment Product
Table 54. Pfizer Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Overactive Bladder Treatment Product
Table 59. Johnson & Johnson Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Medtronic Company Detail
Table 62. Medtronic Business Overview
Table 63. Medtronic Overactive Bladder Treatment Product
Table 64. Medtronic Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 65. Medtronic Recent Development
Table 66. KYORIN Pharmaceutical Company Detail
Table 67. KYORIN Pharmaceutical Business Overview
Table 68. KYORIN Pharmaceutical Overactive Bladder Treatment Product
Table 69. KYORIN Pharmaceutical Revenue in Overactive Bladder Treatment Business (2017-2022) & (US$ Million)
Table 70. KYORIN Pharmaceutical Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Overactive Bladder Treatment Market Share by Type: 2021 VS 2028
Figure 2. Drugs Features
Figure 3. Device Features
Figure 4. Global Overactive Bladder Treatment Market Share by Application in 2021 & 2028
Figure 5. Idiopathic Overactive Bladder Case Studies
Figure 6. Neurogenic Overactive Bladder Case Studies
Figure 7. Overactive Bladder Treatment Report Years Considered
Figure 8. Global Overactive Bladder Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Overactive Bladder Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Overactive Bladder Treatment Market Share by Region: 2021 VS 2028
Figure 11. Global Overactive Bladder Treatment Market Share by Players in 2021
Figure 12. Global Top Overactive Bladder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Treatment as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Overactive Bladder Treatment Revenue in 2021
Figure 14. North America Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Overactive Bladder Treatment Market Share by Country (2017-2028)
Figure 16. United States Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Overactive Bladder Treatment Market Share by Country (2017-2028)
Figure 20. Germany Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Overactive Bladder Treatment Market Share by Region (2017-2028)
Figure 28. China Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Overactive Bladder Treatment Market Share by Country (2017-2028)
Figure 36. Mexico Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Overactive Bladder Treatment Market Share by Country (2017-2028)
Figure 40. Turkey Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Overactive Bladder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Allergan Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 43. Astellas Pharma Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 44. Pfizer Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 45. Johnson & Johnson Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 46. Medtronic Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 47. KYORIN Pharmaceutical Revenue Growth Rate in Overactive Bladder Treatment Business (2017-2022)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed